Related Experiment Video

Updated: Jul 11, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

[Clinicopathological studies of anti-HCV P1P4 core antibody]

A Shibuya1, A Asano, T Tsuchihashi

  • 1Department of Internal Medicine, Kitasato University, School of Medicine, Sagamihara.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|March 1, 1995
PubMed

Insights

Anti-P1P4 core antibody presence correlates with Hepatitis C Virus RNA. A significant reduction in this antibody titer suggests successful interferon therapy, but it does not indicate liver inflammation severity.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C Virus (HCV) infection is a significant global health concern.
  • Accurate monitoring of viral load and treatment efficacy is crucial for managing chronic hepatitis C.
  • The role of specific antibodies, such as anti-P1P4 core antibody, in disease progression and treatment response requires further elucidation.

Purpose of the Study:

  • To evaluate the clinicopathological significance of anti-P1P4 core antibody in patients with Hepatitis C Virus.
  • To assess the correlation between anti-P1P4 antibody presence and Hepatitis C Virus RNA (HCV-RNA) in blood donors.
  • To determine the utility of anti-P1P4 antibody titer changes in monitoring the virological effects of interferon therapy for chronic hepatitis C.

Main Methods:

  • Serum samples from 40 anti-HCV antibody-positive blood donors and 37 patients with chronic hepatitis C treated with interferon were analyzed.
  • Detection of anti-P1P4 core antibody and HCV-RNA.
  • Monitoring of anti-P1P4 antibody titers before and after interferon therapy.

Main Results:

  • A strong correlation was observed between the presence of anti-P1P4 antibody and HCV-RNA in blood donors.
  • A reduction of over 50% in anti-P1P4 antibody titer post-interferon therapy was associated with the disappearance of HCV-RNA.
  • The anti-P1P4 antibody titer did not correlate with the grade of liver inflammation in clinical and pathological assessments.

Conclusions:

  • Anti-P1P4 core antibody is a potential marker for the presence of HCV-RNA.
  • Changes in anti-P1P4 antibody titers can serve as an indicator of the virological response to interferon therapy.
  • Anti-P1P4 antibody levels are not suitable for assessing the severity of liver inflammation in Hepatitis C patients.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...